Overview
Updated 14 Jul 2026
Luciano Costa is Professor of Medicine at University of Alabama at Birmingham. The public record shows 601 publications with 17,045 citations (h-index 61), centered on Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, CAR-T cell therapy research. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 22 companies, 1 NIH-funded awards (2020–2021).
- Most recent indexed publication: 2026 · Cancer
- Top research focus: Multiple Myeloma Research and Treatments
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 22 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 65 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 212.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
Sponsor: University of Alabama at Birmingham
InvestigatorPhase 1/PHASE2Active, not recruitingNCT05434689 - Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
Sponsor: University of Alabama at Birmingham
InvestigatorPhase 2RecruitingNCT05231629 - Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
Sponsor: University of Alabama at Birmingham
InvestigatorPhase 2RecruitingNCT04991103
Industry payments
Updated 14 Jul 2026
22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202521 payments$42,219openpaymentsdata.cms.gov ↗
- Regeneron Pharmaceuticals, Inc.Program year20258 payments$22,443openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20253 payments
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2020–2021 per NIH RePORTER. The latest:
Congress activity
Updated 14 Jul 2026
138 congress contributions (2004–2025) across AACR, ASCO, ASH, SABCS per OpenAlex. The most recent:
- Phase 3 randomized study of teclistamab plus daratumumab versus investigator’s choice of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients (Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3
ASH Annual Meeting
ASH2025Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited worksby citation count (OpenAlex)
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
2000 6th Avenue South, Floor 5, Birmingham, AL 35233
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →commitmyelomatrials.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →commitmyelomatrials.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
Editorial & leadership rolesjournal and society appointments
- Chair
Scientific Steering Committee, coMMit (Myeloma Trials, Innovated)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →commitmyelomatrials.org ↗ - Director
Multiple Myeloma Program, O'Neal Comprehensive Cancer Center, UAB
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →commitmyelomatrials.org ↗ - Director
Immune Effector Cellular Therapy Program, O'Neal Comprehensive Cancer Center, UAB
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →commitmyelomatrials.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →commitmyelomatrials.org ↗
Secondary affiliationsappointments beyond the home institution
- Formerly Associate Professor of Medicine
Medical University of South Carolina; co-chaired Protocol Review Committee, Hollings Cancer Center
2014provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →commitmyelomatrials.org ↗ - Associate Director for Clinical Research
O'Neal Comprehensive Cancer Center at UAB
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myelomacrowd.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- LinkedIn
linkedin.com/in/luciano-j-costa-88a978ba
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Luciano-J-Costa-47268868
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Other
uab.edu/reporter/people/achievements/item/9006-aiming-for-a-cure-against-the-odds-uab-cancer-trial-earns-standing-ovation
- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David Standaert, MD, PhD
University of Alabama at Birmingham
- 455
- publications
- 100
- h-index
- 4
- trials
Pankaj Arora, MD
University of Alabama at Birmingham
- 346
- publications
- 43
- h-index
- 11
- trials
Ashita Tolwani, MD
University of Alabama at Birmingham
- 293
- publications
- 49
- h-index
- 1
- trial
Surya Bhatt, MD
University of Alabama at Birmingham
- 526
- publications
- 56
- h-index
- 6
- trials